Topic:

Packaging and Labeling

Latest Headlines

Latest Headlines

Merck recalls 276,000 bottles of cancer med that could pose risk to children

A packaging problem has led Merck to recall 276,000 bottles of a cancer med because the child-proof feature can fail, allowing children to get their hands on the chemo drug.

Actavis yanks more than half a million boxes of birth control pills for packaging faux pas

For the third time this year, a drugmaker is having to recall birth control pills in North America. This time, it is Actavis, which is voluntarily recalling more than half a million boxes of contraceptives because of packaging problems.

Hospira recalls solution marked as heparin

Hospira is voluntarily recalling 181,704 bags of magnesium sulfate in 5% dextrose injections because labels on the immediate container may have barcodes indicating that it is instead the blood thinner heparin.

Novartis' Sandoz expands Poland plant with packaging facility

Novartis' plant in Stryków, Poland, one of the largest of its Sandoz generics unit, had no packaging lines, forcing the company to transport its production to other facilities for that step in the supply chain. Sandoz will be able to expand capacity at the plant and save on transportation costs now that it has opened a new packaging facility there.

Labeling foul-up involving acetaminophen leads RB to recall 135 lots of Mucinex

The back labels of some bottles of Mucinex cold medicines may not show they contain acetaminophen and other active ingredients, leading U.K.-based Reckitt Benckiser to recall of 135 lots of the popular product in the U.S.

UPDATED: Pfizer accused of misleading consumers with oversized Advil bottles

A federal lawsuit has put an over-the-counter drug packaging practice in the spotlight by trying to extract a penalty from Pfizer for using "nonfunctional slack-fill."

Catalent wraps another Asia-Pacific deal with Pharmapak buy

Drug developer Catalent Pharma Solutions is continuing its expansion in the Asia-Pacific region with the acquisition of a packaging company in Australia.

Lawsuit would force FDA to ban or label wheat gluten as ingredient

Celiac sufferer Michael Weber is suing the FDA for dragging its feet on a citizen petition he filed in 2008. The lawsuit attempts to force the FDA to either ban gluten from use in drugs or at least require labels to indicate it is an ingredient in prescription and over-the-counter drugs.

Arena, Eisai have to recall nearly 122,000 bottles of Belviq over labeling glitch

Arena Pharmaceuticals has seen sales of its weight-loss drug Belviq improve since teaming up with marketing partner Eisai. But the two have hit a manufacturing stumbling block, having to voluntarily recall three lots of the drug because of labeling issues.

Indian drugmakers lambast proposed PET packaging ban

Indian drugmakers are in a dogfight with Indian regulators who have proposed banning the use of PET plastic bottles for some drug packaging. If they have to move to glass, it will add up to 30% to their transportation cost per bottle, they have complained.